it is concluded that midazolam much more effectively suppresses the cardiostimulatory action of ketamine than the increase in icp and that neither a midazolam-ketamine nor a diazepam-ketamine combination should be considered safe for use in patients who may have reduced intracranial compliance .
C0151740
increase
C0022614
ketamine